These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15142841)

  • 1. NF-kappaB activation is required for the development of cardiac hypertrophy in vivo.
    Li Y; Ha T; Gao X; Kelley J; Williams DL; Browder IW; Kao RL; Li C
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1712-20. PubMed ID: 15142841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of MyD88-dependent nuclear factor-kappaB signaling pathway in the development of cardiac hypertrophy in vivo].
    Li YH; Ha TZ; Chen Q; Li CF
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):267-72. PubMed ID: 15854490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.
    Abdelhamid G; El-Kadi AO
    Free Radic Biol Med; 2015 May; 82():1-12. PubMed ID: 25614461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.
    Gupta S; Young D; Sen S
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H20-9. PubMed ID: 15749748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.
    Chandrasekar B; Mummidi S; Perla RP; Bysani S; Dulin NO; Liu F; Melby PC
    Biochem J; 2003 Jul; 373(Pt 2):547-58. PubMed ID: 12729461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.
    Xu T; Tang H; Zhang B; Cai C; Liu X; Han Q; Zou L
    Int J Clin Exp Pathol; 2015; 8(1):530-40. PubMed ID: 25755743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy.
    Gupta S; Purcell NH; Lin A; Sen S
    J Cell Biol; 2002 Dec; 159(6):1019-28. PubMed ID: 12486112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.
    Ha T; Li Y; Gao X; McMullen JR; Shioi T; Izumo S; Kelley JL; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
    Free Radic Biol Med; 2005 Dec; 39(12):1570-80. PubMed ID: 16298682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A20 is dynamically regulated in the heart and inhibits the hypertrophic response.
    Cook SA; Novikov MS; Ahn Y; Matsui T; Rosenzweig A
    Circulation; 2003 Aug; 108(6):664-7. PubMed ID: 12900338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
    Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
    Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice.
    Young D; Popovic ZB; Jones WK; Gupta S
    J Mol Biol; 2008 Sep; 381(3):559-68. PubMed ID: 18620706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
    Zhao L; Wu D; Sang M; Xu Y; Liu Z; Wu Q
    Int Immunopharmacol; 2017 Jul; 48():102-109. PubMed ID: 28499193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
    Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
    Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.
    Madonna R; Geng YJ; Bolli R; Rokosh G; Ferdinandy P; Patterson C; De Caterina R
    J Biol Chem; 2014 Jul; 289(28):19585-98. PubMed ID: 24855642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
    Wang Z; Gao L; Xiao L; Kong L; Shi H; Tian X; Zhao L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30242058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response.
    Beswick RA; Zhang H; Marable D; Catravas JD; Hill WD; Webb RC
    Hypertension; 2001 Feb; 37(2 Pt 2):781-6. PubMed ID: 11230373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nuclear factor κB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules.
    Kumar S; Seqqat R; Chigurupati S; Kumar R; Baker KM; Young D; Sen S; Gupta S
    Free Radic Biol Med; 2011 Jan; 50(1):206-15. PubMed ID: 21047552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.